Pages that link to "Item:Q3078934"
From MaRDI portal
The following pages link to On the Use of Nonparametric Curves in Phase I Trials with Low Toxicity Tolerance (Q3078934):
Displaying 10 items.
- Stochastic approximation and modern model-based designs for dose-finding clinical trials (Q903289) (← links)
- Continual reassessment and related dose-finding designs (Q903292) (← links)
- A Bayesian nonparametric approach to determining a maximum tolerated dose (Q1362182) (← links)
- Flexible link continual reassessment methods for trivariate binary outcome phase I/II trials (Q2320854) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Practical considerations for using functional uniform prior distributions for dose-response estimation in clinical trials (Q2931052) (← links)
- Curve-Free and Model-Based Continual Reassessment Method Designs (Q3078936) (← links)
- Continual reassessment method with multiple toxicity constraints (Q3303685) (← links)
- Bayesian Dose-Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios (Q3436524) (← links)
- A Curve‐Free Method for Phase I Clinical Trials (Q4667490) (← links)
